Musslewhite W. Robert's Insider Trades & SAST Disclosures
Musslewhite W. Robert's most recent trade in Cardinal Health, Inc. was a trade of 1,049 Common Shares done . Disclosure was reported to the exchange on March 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Musslewhite W. Robert.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardinal Health, Inc. | Robert W. Musslewhite | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 1,049 | 1,049 (0%) | 0% | 0 | Common Shares | |
| Costar Group, Inc. | Robert W. Musslewhite | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 3,293 | 15,156 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Definitive Healthcare Corp... | Musslewhite W. Robert | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.00 per share. | 07 Jan 2024 | 14,207 | 1,201,638 | - | 9 | 127,863 | Class A Common Stock |
| Definitive Healthcare Corp... | Robert W. Musslewhite | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.31 per share. | 04 Aug 2023 | 12,657 | 1,248,517 | - | 11.3 | 143,151 | Class A Common Stock |
| Definitive Healthcare Corp... | Robert W. Musslewhite | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.67 per share. | 07 Jul 2023 | 20,016 | 1,261,174 | - | 10.7 | 213,571 | Class A Common Stock |
| Definitive Healthcare Corp... | Robert W. Musslewhite | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. | 04 May 2023 | 53,587 | 1,281,190 | - | 9.9 | 530,511 | Class A Common Stock |
| Definitive Healthcare Corp... | Robert W. Musslewhite | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.47 per share. | 07 Apr 2023 | 15,616 | 1,334,777 | - | 10.5 | 163,500 | Class A Common Stock |
| Definitive Healthcare Corp... | Robert W. Musslewhite | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 368,422 | 1,350,393 | - | 0 | Class A Common Stock | |
| Definitive Healthcare Corp... | Robert W. Musslewhite | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.41 per share. | 07 Jan 2023 | 14,026 | 981,971 | - | 10.4 | 146,011 | Class A Common Stock |
| Definitive Healthcare Corp... | Robert W. Musslewhite | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.82 per share. | 07 Oct 2022 | 70,658 | 995,997 | - | 14.8 | 1,047,152 | Class A Common Stock |
| Costar Group, Inc. | Robert W. Musslewhite | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 3,380 | 8,331 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Definitive Healthcare Corp... | Robert W. Musslewhite | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 333,322 | 983,322 | - | - | Class A Common Stock | |
| Definitive Healthcare Corp... | Robert W. Musslewhite | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 83,333 | 1,066,655 | - | - | Class A Common Stock | |
| Definitive Healthcare Corp... | Robert W. Musslewhite | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 650,000 | 650,000 | - | - | Class A Common Stock | |
| Costar Group, Inc. | Robert W. Musslewhite | Director | Grant, award, or other acquisition of securities at price $ 88.95 per share. | 15 Sep 2021 | 2,811 | 4,951 (0%) | 0% | 88.9 | 250,038 | Common Stock, par value $0.01 per share |
| Costar Group, Inc. | Robert W. Musslewhite | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 214 | 214 (0%) | 0% | 0 | Common Stock, par value $0.01 per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges